Universitätsklinikum C.-G.-Carus Dresden

Dresden, Saxony 01307

1 studies enrolling now · 2 studies all time

What they study most

Cancer, Recurrent Cancer, Refractory Cancer, Solid Tumor, Adult

Studies at this site

• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors — Recruiting now
• TCR-engineered T Cells in Solid Tumors: IMA202-101 — Completed